GRO Biosciences Presents Preclinical Data on Two ProGly™ Programs for Non-Standard Amino Acid Therapies

[#item_full_content]BOSTON–(BUSINESS WIRE)– #antidrugantibodies–GRObio presents ProGly™ data on new modalities for reversing autoimmune disease and eliminating anti-drug antibodies against immunogenic therapies